← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 1999Last known activity
Sep 5, 2018
Timeline
1990s
- Jun 1, 1998
Medivir— Founded
2010s
- Apr 12, 2011
BioPhausia— Acquired
- Nov 4, 2016
TetraLogic Pharmaceuticals— Acquired
Drugs by trial phase (18 distinct, 22 trials)
Phase 2 (2 own, 8 via acquisition)
Phase 1 (0 own, 6 via acquisition)
Indications
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (8)
- NCT03781934Lead sponsorPhase 1/Phase 2Sep 5, 2018
- NCT03443453Lead sponsorPhase 1Jan 19, 2018
- NCT03037489Lead sponsorPhase 2Sep 1, 2016
- NCT02705625Lead sponsorPhase 2Jan 1, 2016
- NCT00735761Lead sponsorPhase 3Dec 1, 2006
- NCT00375570Lead sponsorPhase 3Oct 1, 2006
- NCT00361881Lead sponsorPhase 3Jul 1, 2006
- NCT00736437Lead sponsorPhase 2Aug 1, 1999
Details
- Founded
- Stockholm, SE Jun 1, 1998
- Last known activity
- Sep 5, 2018